Fig. 1 · Structure

Documents & Downloads

DL-Carnitine hydrochloride

Cat. No. A10322 CAS 461-05-2
DL-Carnitine hydrochloride is a quaternary ammonium compound biosynthesized from the amino acids lysine and methionine. In living cells, it is required for the transport of fatty acids from the cytosol into the mitochondria during the breakdown of lipids (fats) for the generation of metabolic energy.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

DL-Carnitine hydrochloride Research Summary

This section summarizes 1 in vitro study of DL-Carnitine hydrochloride from 1 published reference. In vitro models include human SW1353 chondrosarcoma cell line.

DL-Carnitine hydrochloride In Vitro Studies

A doctoral thesis reported that 10 μM DL-carnitine hydrochloride increased IL1-induced MMP13 mRNA in SW1353 cells relative to IL1 alone. This single-concentration screen measured gene expression, not enzyme activity or cartilage protection, and has limited replication information. [1]

Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.

DL-carnitine hydrochloride in an IL1-stimulated MMP13 expression screen

Cell-based study · Human SW1353 chondrosarcoma cell line [1]

In a single-concentration thesis screen, DL-carnitine hydrochloride increased IL1-induced MMP13 mRNA relative to IL1 alone.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
MMP13 gene expression normalized to 18S and expressed relative to IL1-only controlDirection and reported statistical significance Increased; p<0.05 indicated for compound 38; mean ± SEM, n=3. Exact fold change not extracted.[1]

Literature-Reported Treatment Conditions

Treatment concentration
10 μM
Exposure duration
1 h compound pretreatment; 6 h IL1 stimulation as specified in Figure 3.3 caption
Method
Cell treatment followed by qRT-PCR
Vehicle
DMSO stock reported; final DMSO concentration and vehicle matching are not explicitly specified in the selected screen description
Co-treatment
IL1, 5 ng/ml; comparator IL1 alone
Reported limits
n=3 is not identified as biological versus technical replication in Figure 3.3. Exact final solvent control matching is unverified; endpoint is transcript expression, not MMP13 enzyme activity.
Methods and source locations

Compound reported in the paper: DL-carnitine hydrochloride; Compound label in the paper: Compound 38

Limited to the reported single-concentration cell-line screen in a doctoral thesis; no disease efficacy or direct molecular target claim.

printed pp.50–54,60,64–65; appendix p.209

MMP13 gene expression normalized to 18S and expressed relative to IL1-only control: qRT-PCR; one-way ANOVA with Dunnett’s post hoc test per Figure 3.3 caption — printed p.65, section 3.2.3.1, Figure 3.3 and caption; appendix p.209, compound 38

Specifications

Manufacturer Adooq Bioscience
CAS Number 461-05-2
Formula C7H16ClNO3
Molecular Weight 197.66
Synonyms Vitamin BT Hydrochloride
SMILES
C[N+](C)(C)CC(CC(=O)[O-])O.Cl

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 35 mg/mL (177.07 mM)
Water 35 mg/mL (177.07 mM)
Ethanol Insoluble

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

DL-Carnitine hydrochloride Research References

  1. [1] Jonathan Alex Green. Selecting dietary-derived bioactives which protect cartilage from destruction in osteoarthritis University of East Anglia doctoral thesis (2015). Source material

Added to your cart

View Cart Checkout
Loading...